Vivo Capital has announced the closing of its ninth fund with $1.43 billion in committed capital.

The firm indicated it plans to use these funds to invest in and build healthcare and life science companies.

Founded in 1996 and based in Palo Alto, Calif., Vivo is a healthcare-focused investment firm. It has raised more than $4 billion in capital and backed more than 200 private and public portfolio companies since its inception.